Aurobindo Pharma LtdNSE: AUROPHARMA

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated September 30, 2026, titled "Acrotech Biopharma Launches ADQUEY in the U.S. and Establishes Dedicated Dermatology Business".

· Issued by Aurobindo Pharma Ltd via NSE India

View original source (NSE India)

Earlier from Aurobindo Pharma

All Aurobindo Pharma news releases